Public Stem Cell Seminar Fall 2015
F Adult Stem Cell Therapy for Orthopedics and Human Diseases
Saturday, October 10th from 1:00 pm – 3:00 pm
Hilton Dallas/Southlake Town Square
1400 Plaza Place
Southlake, Texas 76092
You are cordially invited to a free public seminar on advances in stem cell therapy for orthopedics and human diseases on October 10th, 2015 at the Hilton Dallas/Southlake Town Square. Attendees will learn about stem cell protocols currently offered at RMI for orthopedic conditions like knee pain,shoulder pain, tendon and ligament injuries, and more. Presenters will also cover clinical trials for a variety of conditions including multiple sclerosis,spinal cord injury, and autism.
Informational presentations by:
Neil Riordan, PA, PhD – Why
Stem Cells Work: Clinical Trials for Spinal Cord Injury, Autism, Multiple Sclerosis, Rheumatoid Arthritis, and Duchenne Muscular Dystrophy
Dr. Riordan is co-founder of Riordan-McKenna Institute and founder of Stem Cell Institute
Wade McKenna, DO – Potential of Stem Cells to Enhance Surgical and Non-Surgical Outcomes in Sports Injuries and Orthopedic Procedures.
Dr. McKenna is co-founder, Riordan-McKenna Institute. He is also founder of McKenna Orthopedics in Decatur, Texas.
Roger Nocera, MD – Cells That Heal Us From Cradle to Grave
Dr. Nocera is the author of “Cells That Heal Us From Cradle To Grave: A Quantum Leap In Medical Science.“ He is founder and president of Amnion Cytokine Therapy and was formerly the chief medical officer of Medistem, Inc.
The presenters will be on hand afterwards for a meet and greet. Light snacks will be served.
Admission is free but space is limited. All attendees must register.
For more information contact:
+1 (817) 776-8155
About Riordan-McKenna Institute (RMI)
RMI specializes in non-surgical treatment of acute and chronic orthopedic conditions using *AlphaGEMS flowable amniotic tissue allograft and bone marrow aspirate concentrate (BMAC) that is harvested using the Bio-MAC (Pat. Pend.) bone marrow aspiration cannula. Common conditions treated include meniscal tears, ACL injuries, rotator cuff injuries,runner’s knee, tennis elbow, and joint pain due to degenerative conditions like osteoarthritis. RMI also uses AlphaPATCH amniotic membranes as part of a complete wound care treatment regimen.
RMI also augments orthopedic surgeries with BMAC and AlphaGEMS to promote better post-surgical outcomes.
BMAC contains a patient’s own mesenchymal stem cells (MSC,) hematopoietic stem cells (CD34+), growth factors and other progenitor cells. AlphaGEMS is composed of collagens and other structural proteins, which provide a biologic matrix that supports angiogenesis, tissue growth and new collagen during tissue regeneration and repair.
*Amniotic Therapies Inc. produces AlphaGEMS and AlphaPATCH products from donated amniotic tissue after normal healthy births. For more information about AlphaGEMS, please visit:
Riordan-McKenna Institute (RMI)
801 E. Southlake Blvd.
Tel: (817) 776-8155
Toll Free: (877) 899-7836
Fax: (817) 776-8154
About Stem Cell Institute Panama
Founded in 2007 on the principle of providing unbiased, scientifically sound treatment options; the Stem Cell Institute (SCI) has matured into the world’s leading adult stem cell therapy and research center. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of autologous bone marrow stem cells, autologous adipose stem cells, and donor human umbilical cord stem cells to treat: autism, cerebral palsy, multiple sclerosis, spinal cord injury, osteoarthritis, rheumatoid arthritis, heart disease, and autoimmune diseases.
In partnership with Translational Biosciences, a subsidiary of Medistem Panama, SCI provides clinical services for ongoing clinical trials that are assessing safety and signs of efficacy for autism, multiple sclerosis, osteoarthritis, rheumatoid arthritis, and spinal cord injury using allogeneic umbilical cord tissue-derived mesenchymal stem cells (hUC-MSC) and hU-MSC-derived mesenchymal trophic factors (MTF). In 2016,Translation Biosciences plans to expand its clinical trial portfolio to include
heart disease and cerebral palsy.
For more information on stem cell
therapy visit the Stem Cell Institute Website:
Stem Cell Institute
Via Israel & Calle 66
Plaza Pacific Office #2A
Panama City, Panama